Retina Eye Center

06/18/2026

We’re grateful for the trust patients place in our team, especially during urgent and stressful situations. Providing timely, thorough care and helping patients feel informed and supported throughout the process is always our priority.

06/16/2026

Specialized care can make a significant difference in diagnosing and treating conditions of the retina, macula, and vitreous. Discover how a retina specialist collaborates with your care team and what to expect during your visit: https://brnw.ch/21x3obw

For over 30 years, The Retina Eye Center has provided patients throughout South Carolina and Georgia with a wide range of retinal diagnostics and treatment. Learn more.

06/11/2026

At The Retina Eye Center, your initial examination is comprehensive and may take 2 to 3 hours, with additional time needed if further testing is required. Learn what to expect during your visit and how to prepare for your appointment: https://brnw.ch/21x3gAN

If you are a new patient with The Retina Eye Center and have questions about your first visit or what forms you need, here is all the information you need.

06/09/2026

Clear central vision helps with everyday activities like reading, driving, and recognizing faces. Learn how problems affecting the macula can impact daily life and why regular eye exams are important for early detection: https://brnw.ch/21x3cG8

06/04/2026

Smoking has been associated with a significantly increased risk of multiple vision-threatening eye conditions. Learn how these findings highlight the impact of lifestyle factors on ocular health and the importance of regular eye care and prevention: https://brnw.ch/21x35wR

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

06/02/2026

Meet Dr. Dhaliwal, a retina specialist with decades of experience and advanced fellowship training. He has contributed to the field through many peer-reviewed publications, reflecting his commitment to advancing retinal care. Learn more: https://brnw.ch/21x31Lp

05/28/2026

A vitrectomy is a surgical procedure used to treat conditions affecting the retina and the back of the eye. Learn more about what to expect during the procedure, and how it can support your vision: https://brnw.ch/21x2TWl

05/26/2026

A treatment for retinal vein occlusion has been approved for longer-term use in managing macular edema. Learn how this development may help patients maintain more consistent care with fewer treatment switches: https://brnw.ch/21x2PII

The decision lengthens the approved treatment period outlined in the prescribing information and may lessen the need to change therapies for patients who continue to show a lasting response.

05/21/2026

Longer dosing intervals are now available for a treatment used in wet age-related macular degeneration and diabetic macular edema. Learn how this update may help reduce treatment visits and support a more manageable care routine for eligible patients: https://brnw.ch/21x2HbD

Regeneron announced that the FDA has amended the EYLEA HD label after the approval, adding 96-week results from the PULSAR wAMD trial and the PHOTON DME trial.

05/20/2026

Research is now underway studying a potential new treatment for wet age-related macular degeneration. Learn what this study could mean for future approaches to supporting retinal health and patient care: https://brnw.ch/21x2EVu

MALBEC (NCT07440225) is a randomized, double-masked trial evaluating the safety and efficacy of MK-8748 at 2 dose levels versus control (aflibercept 2mg).